
Secukinumab now treats moderate to severe hidradenitis suppurativa in patients 12 years and older, making it the first IL‑17A biologic option for teens.

Secukinumab now treats moderate to severe hidradenitis suppurativa in patients 12 years and older, making it the first IL‑17A biologic option for teens.

A study found that prompt blood sugar control following a gestational diabetes diagnosis can reduce a child's risk of obesity.

A study found that day-to-day fluctuations in screen use have a minimal impact on subsequent sleep outcomes among children and adolescents.

Daniel Jaechul Ahn, MD, BS, explains how status exceptions are used to navigate the current 3-status system and why policy reform is necessary.

Researchers have found that reducing parental stress improves parenting behaviors and lowers obesity rates in children.

A study found that high consumption of ultra-processed foods in early childhood is associated with increased risks of anxiety, hyperactivity, and aggression.

Researchers emphasize that while generative AI offers new learning tools for youth, parents must actively supervise its use and prioritize human interaction.

A study found that AI-generated nutrition plans for adolescents undercalculate caloric needs by an average of 700 kcal and skew macronutrient ratios.

A study found that decreased mortality in children awaiting heart transplants is due to improved overall medical care rather than revisions to waitlist allocation rules.

Children with Crohn disease had reduced microbial diversity and increased proinflammatory bacteria vs peers with disorders of brain-gut interaction.

The approval marks the first treatment option for patients with this rare condition.

Mariana Bueno, PhD, RN, discusses the physiological considerations, clinical barriers, and best practices for effectively using sucrose to mitigate procedural pain in infants.

Universal smartphone use during school, specifically frequent checking, is associated with decreased inhibitory control and attentional resources in teens.

A small dose of sucrose administered before painful hospital procedures is a simple and rapid method for reducing pain in newborns.

Researchers discovered that combining stress management with nutrition education improves parenting behaviors and reduces childhood obesity rates.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

New research demonstrates that moderate to high exercise levels before and during pregnancy can significantly enhance early childhood neurodevelopmental.

New data reveal that implementing rapid diagnostic testing for RSV reduces the rate of unnecessary antibiotic prescriptions for viral respiratory infections.

Clesrovimab has been shown to maintain RSV-protection in infants across 2 RSV seasons, while also having positive safety data.

Clinical trial data demonstrate that clesrovimab maintains a safety profile comparable to palivizumab while providing significant protection against RSV-related infections.

Two recent studies offer insights into the success of nonoperative treatments for pediatric spondylolysis and the potential fracture risks linked to growth hormone therapy.

A study found that drying very preterm infants before immediate plastic wrapping offers no improvement in temperature regulation.

A study found that delivering a small dose of sucrose before painful hospital procedures offers simple and rapid pain reduction for newborns.

A study found that designating a Pediatric Emergency Care Coordinator significantly boosts EMS readiness, care coordination, and safety for young patients.

A study found no significant difference in increased intracranial pressure risk between surgical and conservative management for children with metopic synostosis.

Wright joins Schroer for a discussion on updates in pediatric eosinophilic esophagitis at AAAAI 2026.

New data reveal who misses oral food challenges despite scheduling, spotlighting race and insurance gaps—and the barriers clinics can fix.

The expanded approval provides young pediatric patients with a proven, effective treatment to significantly reduce dangerously high LDL-C levels.

Brian Schroer, MD, highlights recent data exploring the origins of EoE inflammation and the efficacy and limitations of recent biologic treatments.

UCB leadership discusses how bridging regulatory approval and real-world access requires integrated care coordination and a long-term commitment to the patient journey.